Bumetanide in Patients With Alzheimer's Disease

Clinical trial NCT06052163 · RECRUITING

Trial details

NCT number: NCT06052163
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-04-10
Primary completion: 2026-12-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.